Vigil immunotherapy tolerated well for recurrent ovarian CA Tx – Medical Xpress
Medical Xpress |
Vigil immunotherapy tolerated well for recurrent ovarian CA Tx
Medical Xpress (HealthDay)—Vigil immunotherapy shows good tolerability for recurrent ovarian cancer patients, and PARP 7, a poly(ADP-ribose) polymerase protein, may play a significant role in survival for ovarian cancer, according to two studies presented at the … |
